Replies to post #3876 on Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

which is what I said earlier.

Maybe you have a different definition of head to head. In my world its one drug vs another, mano a mano, you know like imatinib vs dasatinib.

Whether you care to admit it or not, Dr. Kantarjian specifically suggested that Ariad NOT run a large, head to head trial....which IS exactly what you were suggesting.